- Biden presses Colombia to block biosimilar drugs
- WIPO's new Senior Management Team: New faces for Copyright, Development, Global Issues and Patents
- The Gilead HCV license: Glass half empty, or half full?
- KEI welcomes the Gilead HCV licenses, as a step to expand access to treatments. Notes challenges that remain
- Senator Wyden in 2012, on access to the TPP text
- WIPO General Assembly 2014: Hard Decisions on the Broadcast Treaty and work program on copyright limitations and exceptions
- 13 May 2014: WHO Technical Consultation on Innovative Models for New Antibiotics’ Development and Preservation
- TDR and the Pooled Fund for R&D: WHO demonstration projects and CEWG follow-up
- OMB's Revised Guidance on Appointment of Lobbyists to Federal Advisory Committees, Boards, and Commissions
- Gilead's US patient access programs for Sovaldi
On November 19, 2010, Knowledge Ecology International, Medecins Sans Frontieres/Doctors without Borders, Oxfam America and Public Citizen answered a Request for Comments from the US Department of Commerce on a proposal to "Incentivize Humanitarian Technologies and Licensing Through the Intellectual Property System".
Today I am attending a meeting at the European Parliament on new models of innovation for medical technologies. The event was organized by three MEPs, Thijs Berman, Eva Joly and Carl Schlyter, in collaboration with the European Parliament Working Group on Innovation, Access to Medicines and Poverity-Related Diseaes, and several consumer rights, public health and development NGOs (TACD, Health Action International, KEI, Oxfam and IQsensato).
Non-responsive letter from David Kappos of USPTO to Senators Sanders and Brown regarding ACTA consistency with US lawSubmitted by James Love on 17. November 2010 - 12:56
In a October 19, 2010, Senators Bernard Sanders (I-VT) and Sherrod Brown (D-OH) wrote to David Kappos, the Director of the USPTO, asking for an assessment of conflicts between the October 2010 ACTA text, and U.S. law. (attached here).
|Undersecretary of Commerce for
Intellectual Property, David Kappos
From: James Love
To: Michele Woods
Cc: Nancy Weiss
Subject: Some examples of US inconsistency with ACTA
Date: Fri, 12 Nov 2010 07:29:09 -0500
This note cites several areas where US law is plainly inconsistent with
In addition, in a separate analysis,I have called attention to proposed
legislation in USA on orphan copyrighted works that are very
inconsistent with ACTA provisions on remedies.
Some examples of inconsistencies between ACTA and US law
Sometime very early Saturday morning, SCCR 21 ended with these conclusions.
Communication to SCCR delegates regarding the beneficiaries of a new WIPO treaty for copyright exceptions for disabilitiesSubmitted by thiru on 12. November 2010 - 11:03
12 November 2010
The delegates to the SCCR are considering various proposals to deal with expanded access to copyrighted works by persons who are blind or who have other disabilities.
The proposal sponsored by Brazil, Ecuador, Mexico and Paraguay would extend the benefits of the treaty, not only to persons who are blind or visually impaired, but also as follows:
This was our 400 word statement at the WIPO SCCR 21.
Statement of KEI at WIPO SCCR 21, November 11, 2010
There should be a compelling rationale for creating new global norms for copyrights.
KEI opposes work on a new broadcasting treaty, and supports work on performers treaty.
KEI supports work at the SCCR on new possible norms for copyright limitations and exceptions, particularly as regards to access to knowledge, and uses of new technologies.
Today, Wednesday November 10 2010, during the 3rd day of the WIPO SCCR21, the Group B presented a proposal for a Work Program on copyright exceptions and limitations for the WIPO SCCR. Group B is the negotiation group that groups developed countries like US, EU, Switzerland and others.
The proposal is available here
The following proposal for a road map for the SCCR's consideration of limitations and exceptions was submitted by the African Group on Tuesday, 9 November 2010.
(Limitations and exceptions)
Bearing in mind
- the Development Agenda recommendations;
SAVE THE DATE (10 November 2010): What should the WIPO SCCR do about limitations & exceptions: the way forward?Submitted by thiru on 9. November 2010 - 9:50
On 10 November 2010, Knowledge Ecology International will hold a side event from 13:30 to 14:45 in the Uchtenhagen room at WIPO which shall address the question, "What should the WIPO SCCR do about limitations & exceptions: the way forward"? Speakers include representatives from the Centre for Internet & Society, Egypt, the International Publishers Association, KEI and the South Centre. This is an open event. Please see below for details.
What should the WIPO SCCR do about limitations & exceptions: the way forward?
Invitation to the KEI side bar event
SCCR 21: General statement of Group B (covering broadcasting, AV protection and limitations and exceptions)Submitted by thiru on 9. November 2010 - 0:18
The following general statement was delivered by France, on behalf of Group B, on the first day (8 November 2010) of SCCR 21.
Group B opening statement
I thank you M. Chair,
Group B is glad to welcome you back in Geneva for this 21st session of the Standing Committee on Copyright and Related Rights, which we hope will be a productive one.
The 21st session of the WIPO Standing Committee on Copyright and Related Rights (SCCR) commenced its work at 10:33 AM on Monday, 8 November 2010.
This unusually quick start is perhaps indicative of Member States' commitment to examine the three substantive agenda items up for consideration during this five day negotiation; these three issues include: 1) protection of broadcasting organizations, 2) protection of audiovisual performances and 3) limitations and exceptions.
Global Fund calls upon drug companies to "share without delay" AIDS drug patents with the Medicines Patent PoolSubmitted by Judit Rius on 5. November 2010 - 9:44
In a October 7, 2010 letter, Professor Michel Kazatchkine, the Executive Director of the Global Fund to fight AIDS, Tuberculosis and Malaria, has written to Dr. Jorge Bermudez, the UNITAID Executive Director, to discuss the Medicines Patent Pool.
Kazatchkine congratulates UNITAID for the announcement that an agreement had been reached between U.S. National Institute for Health and the Medicines Patent Pool for the voluntary license of the NIH patents rights on an HIV-AID drug, Darunavir.